Skip to main content
Getinge logo

Getinge — Investor Relations & Filings

Ticker · GETI ISIN · SE0000202624 LEI · 5493003PZ4F570G3W735 ST Manufacturing
Open in API
Filings indexed 648 across all filing types
Latest filing 2008-09-15 M&A Activity
Country SE Sweden
Listing ST GETI

About Getinge

https://www.getinge.com/int/

Getinge is a global medical technology company that provides products and solutions for hospitals and life science institutions. The company's offerings are designed to improve clinical outcomes and support healthcare professionals. Its portfolio is focused on three main areas: Acute Care Therapies, Life Science, and Surgical Workflows. Key products include equipment and systems for intensive care, cardiovascular procedures, operating rooms, and sterile reprocessing. Notable solutions feature advanced ventilators like the Servo-u, extracorporeal life support systems such as Cardiohelp II, and equipment for biopharmaceutical production. The company also offers training and educational services to enhance clinical expertise.

Recent filings

Filing Released Lang Actions
M&A Activity 2008
M&A Activity Classification · 98% confidence The document is an announcement by Getinge AB regarding its agreement to acquire Datascope Corp. for a specific cash price per share. It details the strategic rationale, financial impact (including expected accretion and financing plans involving a credit facility and a future share issue), and provides financial highlights of the target company (sales, EBITDA, assets as of June 30, 2008). This content strongly aligns with an announcement concerning a major corporate transaction, specifically a merger or takeover bid. The most appropriate category is 'M&A Activity' (TAR). It is not a full Annual Report (10-K), an Earnings Release (ER), or a simple Capital/Financing Update (CAP), as the primary focus is the acquisition itself.
2008-09-15 English
M&A Activity 2008
M&A Activity Classification · 99% confidence The document is a press release from Getinge AB announcing the binding agreement to acquire Datascope Corp. It details the financial terms of the acquisition (\$53 per share, total valuation, EBITDA multiple), the strategic rationale (strengthening the cardiovascular division), financing plans (new credit facility and a rights issue), and includes forward-looking statements regarding EPS contribution. This type of announcement, detailing a major corporate transaction like an acquisition, falls under the category of Capital/Financing Update (CAP) as it directly concerns a significant change in the company's capital structure and financing activities, although it is also related to M&A (TAR). Given the detailed financial structure and funding mechanism described, CAP is highly appropriate. However, since the core event is a takeover/merger proposal, TAR (M&A Activity) is also a strong candidate. Since the document focuses heavily on the *financing* of the deal (new credit facility, rights issue), CAP is slightly more specific to the content presented than the general TAR category, which often covers the initial bid/proposal itself. I will classify it as TAR because the primary event is the acquisition/takeover bid, which is the definition of TAR.
2008-09-15 Swedish
Interim / Quarterly Report 2008
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive financial report covering the period of January to June (half-year/interim). It contains detailed financial data, including income statements, segment performance (Medical Systems), order intake analysis, and management commentary on business trends and outlook. It is not a short announcement or a certification, but a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. H1 2008
2008-07-14 Swedish
Interim / Quarterly Report 2008
Interim / Quarterly Report Classification · 100% confidence The document provides detailed financial results for a six-month period (January–June) and the second quarter, including specific line items like orders received, net sales, profit before tax, and EBITA. It contains comprehensive financial tables and management commentary on business performance, which is characteristic of an interim or quarterly financial report. It is not an earnings release (which is typically a short summary) nor a report publication announcement (as it contains substantive data). H1 2008
2008-07-14 English
Earnings Release 2008
Earnings Release Classification · 99% confidence The document discusses specific financial charges related to integration and restructuring costs for the second quarter and the full year (2008). It details expected costs, savings, and the nature of the activities (integration of acquired divisions). This content is characteristic of an announcement detailing financial performance impacts outside of a full annual or interim report, often released to update the market on specific financial events or operational changes. It is not a full report (10-K or IR), a transcript (CT), or a dividend notice (DIV). Since it provides specific financial updates and operational context, it aligns best with either an Earnings Release (ER) or Management Discussion/Analysis (MDA). Given the focus is purely on the costs/savings from integration rather than a comprehensive review of all revenues and expenses for a period, it functions as a specific financial update. In the context of the provided definitions, 'ER' (Earnings Release) is the closest fit for a focused financial update announcement, although 'MDA' (Management Reports) could also apply if this were part of a larger discussion. However, as a standalone announcement detailing specific financial impacts, ER is the most appropriate classification for a focused financial update outside of a formal quarterly filing. Q2 2008
2008-07-07 English
Earnings Release 2013
Earnings Release Classification · 98% confidence The document is a press release from Getinge AB, written in Swedish, titled "Getinge AB preciserar integrations- och omstruktureringskostnader för årets andra kvartal och för helåret" (Getinge AB specifies integration and restructuring costs for the second quarter and the full year). It details specific financial impacts (costs and savings) related to the integration of Huntleigh and cardiovascular surgery divisions for Q2 and the full year. This content—providing key financial highlights and updates on specific operational/financial events outside of a full periodic report—is characteristic of an Earnings Release (ER). It is not a full report (10-K or IR), a transcript (CT), or a management discussion (MDA), but rather a focused announcement of financial outcomes for a period. Q2 2013
2008-07-07 Swedish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.